![Ellsworth Roston](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ellsworth Roston
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Marvin Fink | M | 88 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 anni |
Lee B. Ehrlichman | M | 77 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Lowell T. Harmison | M | 87 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Robert G. Koblin | M | 92 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 4 anni |
Pamela M. Bunes | F | 61 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 anni |
Budimir S. Drakulic | M | 74 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 6 anni |
Jennifer Black | F | 68 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 6 anni |
Jay A. Johnson | M | 63 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 anni |
Bruce Richman | M | - |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
William Robert Matthews | M | 69 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 5 anni |
Robert C. Scherne | M | 67 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Rodney Hildebrandt | M | - |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 anni |
Norma Provencio | F | 67 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Elizabeth Peacock | F | - |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Charles H. Harrison | M | 81 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 anni |
Jesse S. Rosas | M | 65 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Steven Joseph Phillips | M | - |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Robert E. Windom | M | - |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
Willie Gault | M | 63 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 anni |
Kevin F. Pickard | M | 59 |
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 20 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ellsworth Roston
- Contatti personali